TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
Research from A.R. Martineau et al broadens understanding of tuberculosis
February 17th, 2009
According to recent research from London, the United Kingdom, "Newham Chest Clinic, London, UK. To determine the safety and efficacy of the administration of bolus-dose vitamin D-2 in elevating serum 25-hydroxyvitamin D (25[OH]D) concentrations in tuberculosis (TB) patients." "A multi-ethnic cohort of TB patients was randomised to receive a single oral dose of 2.5 mg vitamin D-2 (n= 11) or placebo (n = 14). Serum 25(OH)D and corrected calcium concentrations were determined at baseline and 1 week and 8 weeks post-dose, and compared to those of a multi-ethnic cohort of 56 healthy adults receiving an identical dose of vitamin D-2. Hypovitaminosis D (serum 25[OH]D < 75...
Source: TB & Outbreaks Week (2009-02-17)
|
